4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-005374
Director acquired 1,548 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anderson Kenneth Carl Director | 2021-01-22 | Option exercise | +538 | $2.11 | $1,135 | 80,914 | D |
| Anderson Kenneth Carl Director | 2021-01-22 | Option exercise | +121 | $2.11 | $255 | 81,035 | D |
| Anderson Kenneth Carl Director | 2021-01-22 | Option exercise | +889 | $4.98 | $4,427 | 81,924 | D |
| Derivatives | |||||||
| Anderson Kenneth Carl Director | 2021-01-22 | Option exercise · Stock Option (Right to Buy) | −538 | 3,207 | D | ||
| Anderson Kenneth Carl Director | 2021-01-22 | Option exercise · Stock Option (Right to Buy) | −121 | 0 | D | ||
| Anderson Kenneth Carl Director | 2021-01-22 | Option exercise · Stock Option (Right to Buy) | −889 | 4,446 | D | ||
Loading xslF345X03/doc4.xml…